Guardian Pharmacy Services Income Statement (2023-2025) | GRDN

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 262.74M281.07M275.41M300.04M314.39M338.57M329.31M344.33M377.43M
Cost of Revenue 210.55M226.49M220.31M238.75M253.51M271.46M264.96M276.19M302.71M
Gross Profit 52.19M54.58M55.10M61.29M60.88M67.10M64.35M68.15M74.72M
Operating items
Selling, General & Administrative 58.52M39.05M47.17M44.28M165.49M50.35M51.34M55.57M58.37M
Operating Expenses 58.52M39.05M47.17M44.28M165.49M50.35M51.34M55.57M58.37M
Operating Income -6.33M15.52M7.93M17.00M-104.61M16.75M13.01M12.58M16.35M
EBIT -6.33M15.52M7.93M17.00M-104.61M16.75M13.01M12.58M16.35M
Non-operating items
Other Non Operating Income 0.05M-0.23M-0.07M-0.09M-0.00M-0.11M0.27M0.18M0.44M
Non Operating Income -0.67M-0.96M-0.84M-1.16M-1.03M-0.53M0.27M0.18M0.44M
Net income details
EBT -7.00M14.56M7.09M15.85M-105.64M16.22M13.11M12.59M16.63M
Tax Provisions 0.18M4.38M3.83M3.76M7.04M
Profit After Tax -7.00M14.56M7.09M15.85M-121.99M11.94M9.45M9.03M9.82M
Income from Non-Controlling Interests 4.29M2.54M4.31M5.22M6.82M-0.10M-0.17M-0.20M-0.23M
Income from Continuing Operations -7.00M14.56M7.09M15.85M-105.82M11.84M9.27M8.83M9.59M
Consolidated Net Income -7.00M14.56M7.09M15.85M-105.82M11.84M9.27M8.83M9.59M
Income towards Parent Company -7.00M14.56M7.09M15.85M-105.82M11.84M9.27M8.83M9.59M
Net Income towards Common Stockholders -7.00M14.56M7.09M15.85M-105.82M11.84M9.27M8.83M9.59M
Additional items
EPS (Basic) -2.000.190.150.150.16
EPS (Weighted Average and Diluted) -2.000.190.150.140.15
Shares Outstanding (Weighted Average) 61.14M62.01M62.04M62.05M62.12M
Shares Outstanding (Diluted Average) 61.14M62.01M62.91M63.20M63.43M
EBITDA -6.33M15.52M7.93M17.00M-104.61M16.75M13.01M12.58M16.35M
Interest Expenses 0.72M0.74M0.77M1.07M1.03M0.42M0.17M0.17M0.16M
Tax Rate -0.17%27.00%29.25%29.87%42.32%